NEXS Research & Development Group, Inc. Partners With BLVD Medical: To Address National PPE Shortages and Counterfeit Medical Supplies

NEXS Research & Development Group is proud to announce a major advancement in its efforts to protect frontline medical, research, and pharmaceutical staff.

In partnership with BLVD Medical, NEXS is bringing affordable personal protective equipment (PPE) to underserved practitioners nationwide.

Over the past year of COVID preparedness and resistance, BLVD Medical has stepped up to bring life-saving PPE to small-to mid-size businesses and institutions, as well as state agencies and local municipalities. BLVD Medical’s experience and supplier relationships have helped clients side-step the pitfalls presented by opportunists in the PPE industry, and BLVD has cultivated a track record of reliable delivery and client loyalty.

“This partnership will enable our company to extend our reach into the medical distribution sector and support national efforts in the prevention of the spread of COVID-19,” says Dr. Marc Nelson, Chairman of the Board at NEXS Research & Development Group.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”